Skip to main content
OpenTrials

Clinical trial condition

Testicular Germ Cell Tumor

Explore clinical trials studying Testicular Germ Cell Tumor. Study availability and eligibility vary by location and protocol.

59 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Testicular Germ Cell Tumor trial results

Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

NCT06276491

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +27 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Palo Alto, California, United States
  • University of California San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 18 locations
View Trial Details
Not Yet Recruiting

Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care

NCT07699640

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +12 more
Locations
  • Helsinki University Hospital Helsinki, Finland
  • University of Turku Turku, Finland
  • University Hospital Ulm Ulm, Baden-Wurttemberg, Germany
  • University Hospital Würzburg Würzburg, Bavaria, Germany
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

NCT00104676

Conditions
Carcinoma, Embryonal, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Centre Paul Papin Angers, France
  • Institut Bergonie Bordeaux, France
  • C.H.U. de Brest Brest, France
View all 24 locations
View Trial Details
Completed

Diagnostic Study of Patients With Stage I Testicular Cancer

NCT00003800

Conditions
Carcinoma, Embryonal, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View Trial Details
Completed

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

NCT00003518

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
Locations
  • CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
View all 19 locations
View Trial Details

Related conditions